As part of a complete all-in-one system, Sentry LabelBand securely seals inexpensive paper labels inside a clear, adhesive shield. LabelBand provides easy and accurate bar code scanning and protectio
PDCs computer-generated Thermal Printing Wristbands and Tags print in mere seconds through direct thermal and thermal transfer printers. Direct thermal printers use heat to activate a heat-sensitive
A unique and cost effective one-piece adhesive closure patient bracelet with a tamper- resistant feature that has been designed for patient comfort, caregiver productivity, and long term durability.
...nd is desired for adults and where an easy to appl.... The design allows for two bands to be produced a... the second to be held in reserve, should the firs... in a hospital situation wherea band may need to b...
Medicine Products:(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3(Date:8/19/2008)...EGO, Aug. 19 /- Vical Incor...h collaboration with the Karolinska,Institute, a l...h Institute,for Infectious Disease Control (SMI), ...Vaxfectin(R) adjuvant with the Biojector(R) 2000,n...ologies Inc.,OTCBB:BJCT) for a multivalent preven...
(Date:8/18/2008)...LEM, Israel, August 18 /- O...p://www.oramed.com ), a developer,of oral delivery...led "Open,Label Study to Assess the Safety, Pharma...Oral Insulin Formulations in Healthy,Subjects," ha...h Annual,Meeting of the European Association for t...
(Date:8/17/2008)..., Australia, Aug. 17 /Xinhua-PRNewswire-FirstCall/...nced that the first pivotal Phase 3,clinical trial...s has,completed enrolment., The first efficacy da...ng the first half of 2009. The trial commenced its...ecruitment target of 250 subjects in June,2008 and...
(Date:8/14/2008)...cell engaging antibody (BiTE) showing clinical ben...ents own T cells to recognize and attack ...Aug. 14 /- Micromet, Inc.,(...oping novel, proprietary,antibodies for the treatm...s, today announced publication of a Phase 1 clinic...
Breaking Medicine Technology:Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6Adoption of Minimally Invasive Prostate Cancer Treatment Options Slow 22787 1Adoption of Minimally Invasive Prostate Cancer Treatment Options Slow 22787 2Country Music Star Trace Adkins to Be Honorary Chair of Nationwide Walk for Food Allergy 22782 1Country Music Star Trace Adkins to Be Honorary Chair of Nationwide Walk for Food Allergy 22782 2Country Music Star Trace Adkins to Be Honorary Chair of Nationwide Walk for Food Allergy 22782 3Catalyst Pharmaceutical Partners Inc Set to Join Russell Microcap 28R 29 Index 22777 1Catalyst Pharmaceutical Partners Inc Set to Join Russell Microcap 28R 29 Index 22777 2Catalyst Pharmaceutical Partners Inc Set to Join Russell Microcap 28R 29 Index 22777 3Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community Associ 2523 1Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community Associ 2523 2Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community Associ 2523 3Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community Associ 2523 4Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community Associ 2523 5...an Association for Cancer Research,annual meeting ...stCall/ --,Medarex, Inc. today presented preclinic...from two separate studies exploring the,efficacy a...D70,antibody-drug conjugates. CD19 and CD70 are bo...te approach to cancer therapy. They are,expressed ...
...7, 2007 at AACR, SAN DIEGO, April 17 /PRNewswire-F...d data from an in vitro study showing,that the act...NK),cell-mediated anti-tumor response by inducing ...nhanced antibody-dependent cellular,cytotoxicity (...Meeting of the American Association of Cancer Rese...
Other Medicine Technology:Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 2Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 3Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 4Anadys Reports Preclinical Data Showing ANA773 Promotes Anti-Tumor,Activity of Natural Killer Cells 2Anadys Reports Preclinical Data Showing ANA773 Promotes Anti-Tumor,Activity of Natural Killer Cells 3Anadys Reports Preclinical Data Showing ANA773 Promotes Anti-Tumor,Activity of Natural Killer Cells 4